Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.

George J, Nihal M, Singh CK, Ahmad N.

Mol Carcinog. 2019 Oct;58(10):1876-1885. doi: 10.1002/mc.23080. Epub 2019 Jul 10.

PMID:
31292999
2.

Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma.

Denu RA, Shabbir M, Nihal M, Singh CK, Longley BJ, Burkard ME, Ahmad N.

Mol Cancer Res. 2018 Mar;16(3):517-527. doi: 10.1158/1541-7786.MCR-17-0197. Epub 2018 Jan 12.

3.

Histone Deacetylase Inhibitory Approaches for the Management of Osteoarthritis.

Singh CK, Nihal M, Ahmad N.

Am J Pathol. 2016 Oct;186(10):2555-8. doi: 10.1016/j.ajpath.2016.08.001. Epub 2016 Aug 22.

4.

c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.

Nihal M, Wood GS.

Oncotarget. 2016 Aug 16;7(33):53869-53880. doi: 10.18632/oncotarget.10861.

5.

Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human Melanoma.

George J, Nihal M, Singh CK, Zhong W, Liu X, Ahmad N.

J Invest Dermatol. 2016 Apr;136(4):809-818. doi: 10.1016/j.jid.2015.12.026. Epub 2015 Dec 29.

6.

Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach.

Singh CK, Kaur S, George J, Nihal M, Pellitteri Hahn MC, Scarlett CO, Ahmad N.

Oncotarget. 2015 Apr 30;6(12):10335-48.

7.

Sirtuin deacetylases: a new target for melanoma management.

Wilking MJ, Singh CK, Nihal M, Ndiaye MA, Ahmad N.

Cell Cycle. 2014;13(18):2821-6. doi: 10.4161/15384101.2014.949085.

8.

Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model.

Singh CK, Ndiaye MA, Siddiqui IA, Nihal M, Havighurst T, Kim K, Zhong W, Mukhtar H, Ahmad N.

Oncotarget. 2014 Jun 15;5(11):3651-61.

9.

Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.

Siddiqui IA, Bharali DJ, Nihal M, Adhami VM, Khan N, Chamcheu JC, Khan MI, Shabana S, Mousa SA, Mukhtar H.

Nanomedicine. 2014 Nov;10(8):1619-26. doi: 10.1016/j.nano.2014.05.007. Epub 2014 Jun 3.

PMID:
24965756
10.
11.

SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation.

Wilking MJ, Singh C, Nihal M, Zhong W, Ahmad N.

Arch Biochem Biophys. 2014 Dec 1;563:94-100. doi: 10.1016/j.abb.2014.04.001. Epub 2014 Apr 18.

12.

Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach.

Singh CK, George J, Nihal M, Sabat G, Kumar R, Ahmad N.

Oncotarget. 2014 Apr 15;5(7):1987-99.

13.

SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.

Nihal M, Ahmad N, Wood GS.

Cell Cycle. 2014;13(4):632-40. doi: 10.4161/cc.27523. Epub 2013 Dec 16. Erratum in: Cell Cycle. 2015;14(8):1337.

PMID:
24343700
14.

Skin, reactive oxygen species, and circadian clocks.

Ndiaye MA, Nihal M, Wood GS, Ahmad N.

Antioxid Redox Signal. 2014 Jun 20;20(18):2982-96. doi: 10.1089/ars.2013.5645. Epub 2013 Nov 21. Review.

15.

Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.

Xu W, Siddiqui IA, Nihal M, Pilla S, Rosenthal K, Mukhtar H, Gong S.

Biomaterials. 2013 Jul;34(21):5244-53. doi: 10.1016/j.biomaterials.2013.03.006. Epub 2013 Apr 11.

16.

Numb regulates stability and localization of the mitotic kinase PLK1 and is required for transit through mitosis.

Schmit TL, Nihal M, Ndiaye M, Setaluri V, Spiegelman VS, Ahmad N.

Cancer Res. 2012 Aug 1;72(15):3864-72. doi: 10.1158/0008-5472.CAN-12-0714. Epub 2012 May 16.

17.

Enhancing the bioavailability of resveratrol by combining it with piperine.

Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N.

Mol Nutr Food Res. 2011 Aug;55(8):1169-76. doi: 10.1002/mnfr.201100117. Epub 2011 Jun 29.

18.

Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis.

Nihal M, Stutz N, Schmit T, Ahmad N, Wood GS.

Cell Cycle. 2011 Apr 15;10(8):1303-11. Epub 2011 Apr 15.

PMID:
21436619
19.

Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphoma.

Stutz N, Nihal M, Wood GS.

Br J Dermatol. 2011 Apr;164(4):814-21. doi: 10.1111/j.1365-2133.2010.10128.x. Epub 2011 Jan 28.

PMID:
21070201
20.

Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).

Wu J, Siddiqui J, Nihal M, Vonderheid EC, Wood GS.

Arch Biochem Biophys. 2011 Apr 15;508(2):185-91. doi: 10.1016/j.abb.2010.10.020. Epub 2010 Oct 29.

21.

Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).

Nihal M, Roelke CT, Wood GS.

Pharm Res. 2010 Jun;27(6):1103-14. doi: 10.1007/s11095-010-0054-5. Epub 2010 Mar 16.

PMID:
20232120
22.

Polo-like kinase 1 (Plk1) in non-melanoma skin cancers.

Schmit TL, Zhong W, Nihal M, Ahmad N.

Cell Cycle. 2009 Sep 1;8(17):2697-702. Epub 2009 Sep 2.

23.

(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma.

Nihal M, Ahsan H, Siddiqui IA, Mukhtar H, Ahmad N, Wood GS.

Cell Cycle. 2009 Jul 1;8(13):2057-63. Epub 2009 Jul 27.

24.

Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Jung-Hynes B, Nihal M, Zhong W, Ahmad N.

J Biol Chem. 2009 Feb 6;284(6):3823-32. doi: 10.1074/jbc.M807869200. Epub 2008 Dec 15.

25.

Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.

Wu J, Nihal M, Siddiqui J, Vonderheid EC, Wood GS.

J Invest Dermatol. 2009 May;129(5):1165-73. doi: 10.1038/jid.2008.309. Epub 2008 Oct 16.

26.

Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.

Reagan-Shaw S, Nihal M, Ahsan H, Mukhtar H, Ahmad N.

Prostate. 2008 Nov 1;68(15):1624-34. doi: 10.1002/pros.20824.

27.

Dose translation from animal to human studies revisited.

Reagan-Shaw S, Nihal M, Ahmad N.

FASEB J. 2008 Mar;22(3):659-61. Epub 2007 Oct 17.

PMID:
17942826
28.

Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.

Yang B, O'Herrin S, Wu J, Reagan-Shaw S, Ma Y, Nihal M, Longley BJ.

J Invest Dermatol. 2007 Feb;127(2):267-75. Epub 2006 Sep 7.

31.
32.

Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential.

Nihal M, Mikkola D, Horvath N, Gilliam AC, Stevens SR, Spiro TP, Cooper KD, Wood GS.

Hum Pathol. 2003 Jun;34(6):617-22.

PMID:
12827617
33.

Folliculotropic mycosis fungoides with central nervous system involvement: demonstration of tumor clonality in intrafollicular T cells using laser capture microdissection.

Ke MS, Kamath NV, Nihal M, Mikkola DL, Koc ON, Stevens SR, Gilliam AC, Cooper KD, Wood GS.

J Am Acad Dermatol. 2003 Feb;48(2):238-43.

PMID:
12582395
34.

Primary cutaneous large B-cell lymphoma of the leg relapsing as cutaneous intravascular large B-cell lymphoma.

Kamath NV, Gilliam AC, Nihal M, Spiro TP, Wood GS.

Arch Dermatol. 2001 Dec;137(12):1657-8. No abstract available.

PMID:
11735727
35.

Does the difference in the timing of eclosion of the fruit fly Drosophila melanogaster reflect differences in the circadian organization?

Sheeba V, Nihal M, Mathew SJ, Swamy NM, Chandrashekaran MK, Joshi A, Sharma VK.

Chronobiol Int. 2001 Jul;18(4):601-12.

PMID:
11587084
36.

The clonality of tumor-infiltrating lymphocytes in African Kaposi's sarcoma.

Nihal M, Mikkola D, Qian Z, Remick SC, Wood GS.

J Cutan Pathol. 2001 Apr;28(4):200-5.

PMID:
11426827
37.

Anetoderma arising in cutaneous B-cell lymphoproliferative disease.

Kasper RC, Wood GS, Nihal M, LeBoit PE.

Am J Dermatopathol. 2001 Apr;23(2):124-32.

PMID:
11285407

Supplemental Content

Support Center